The price shown is the price for the full 10-vial kit, with no account or approval needed
Then, after the second month, theyll reassess and potentially increase to 1 mg, then 2 mg after another month if necessary
Clinical outcomes such as cirrhosis progression, liver transplant, and all-cause mortality are recognized as solid endpoints for evaluating drug efficacy in MASLD
Network meta-analyses suggest that higher-dose semaglutide (1 mg and 2 mg weekly) and tirzepatide (a dual GIP/GLP-1 receptor agonist) demonstrate superior A1c reductions compared to other agents in the class, with mean reductions of 1.52.0% or greater from baseline
Seventeen studies including observational studies, experimental studies, and narrative reviews were included in the review
Marketing materials for patient recruitment must match the regulatory status of the investigational product